A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Astellas Pharma Inc
Astellas Pharma Inc
Hoffmann-La Roche
Washington University School of Medicine
Washington University School of Medicine
Seagen Inc.
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
University of California, San Diego
National Cancer Institute (NCI)
Takeda
University of Washington
Stanford University
National Cancer Institute (NCI)
University of Connecticut
Dana-Farber Cancer Institute
Tempus AI
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)
Novartis
Johns Hopkins University
NGM Biopharmaceuticals, Inc
University of Oxford
Elevation Oncology
Kymab Limited
MacroGenics
Alliance for Clinical Trials in Oncology
Stanford University
Pfizer
BeiGene
Highlight Therapeutics
TopAlliance Biosciences
Merck Sharp & Dohme LLC
BioNTech SE
Janssen Pharmaceutical K.K.
Adaptimmune
University of Oxford
ADC Therapeutics S.A.
Five Prime Therapeutics, Inc.
Hoosier Cancer Research Network
Cancer Research and Biostatistics Clinical Trials Consortium
Apexigen America, Inc.
Ludwig Institute for Cancer Research
Duke University
Stanford University
Jiangsu HengRui Medicine Co., Ltd.
Memorial Sloan Kettering Cancer Center
University of Nebraska
Massachusetts General Hospital
pharmaand GmbH
Big Ten Cancer Research Consortium